UBS AM’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.77M | Sell |
154,186
-34,116
| -18% | -$477K | ﹤0.01% | 1917 |
|
|
2026
Q1 | $1.77M | Sell |
188,302
-7,885
| -4% | -$86.6K | ﹤0.01% | 2095 |
|
|
2025
Q4 | $2.44M | Sell |
196,187
-6,769
| -3% | -$90K | ﹤0.01% | 1807 |
|
|
2025
Q3 | $2.91M | Sell |
202,956
-105,183
| -34% | -$1.44M | ﹤0.01% | 1605 |
|
|
2025
Q2 | $3.78M | Buy |
308,139
+63,804
| +26% | +$926K | ﹤0.01% | 1835 |
|
|
2025
Q1 | $5.37M | Buy |
244,335
+45,693
| +23% | +$1.07M | ﹤0.01% | 1532 |
|
|
2024
Q4 | $4.51M | Buy |
198,642
+28,457
| +17% | +$621K | ﹤0.01% | 1656 |
|
|
2024
Q3 | $3.09M | Sell |
170,185
-466
| -0.3% | -$10.8K | ﹤0.01% | 1804 |
|
|
2024
Q2 | $4.97M | Buy |
170,651
+53,412
| +46% | +$1.58M | ﹤0.01% | 1492 |
|
|
2024
Q1 | $4.16M | Sell |
117,239
-257
| -0.2% | -$10.3K | ﹤0.01% | 1338 |
|
|
2023
Q4 | $5.12M | Hold |
117,496
| – | – | ﹤0.01% | 1231 |
|
|
2023
Q3 | $4.49M | Buy |
117,496
+1,334
| +1% | +$56.1K | ﹤0.01% | 1253 |
|
|
2023
Q2 | $6.67M | Hold |
116,162
| – | – | ﹤0.01% | 1112 |
|
|
2023
Q1 | $6.67M | Buy |
116,162
+15,512
| +15% | +$874K | ﹤0.01% | 1112 |
|
|
2022
Q4 | $5.64M | Buy |
100,650
+8,741
| +10% | +$445K | ﹤0.01% | 1129 |
|
|
2022
Q3 | $3.89M | Sell |
91,909
-22,360
| -20% | -$1.15M | ﹤0.01% | 1288 |
|
|
2022
Q2 | $6.17M | Buy |
114,269
+1,936
| +2% | +$116K | ﹤0.01% | 1138 |
|
|
2022
Q1 | $7.22M | Buy |
112,333
+6,995
| +7% | +$461K | ﹤0.01% | 1195 |
|
|
2021
Q4 | $7.06M | Sell |
105,338
-2,967
| -3% | -$201K | ﹤0.01% | 1255 |
|
|
2021
Q3 | $7.42M | Buy |
108,305
+510
| +0.5% | +$36K | ﹤0.01% | 1204 |
|
|
2021
Q2 | $7.36M | Buy |
107,795
+1,836
| +2% | +$130K | ﹤0.01% | 1221 |
|
|
2021
Q1 | $7.32M | Sell |
105,959
-11,034
| -9% | -$748K | ﹤0.01% | 1191 |
|
|
2020
Q4 | $7.6M | Buy |
116,993
+15,896
| +16% | +$855K | ﹤0.01% | 1146 |
|
|
2020
Q3 | $4.77M | Buy |
101,097
+5,509
| +6% | +$262K | ﹤0.01% | 1162 |
|
|
2020
Q2 | $4.49M | Sell |
95,588
-2,573
| -3% | -$126K | ﹤0.01% | 1159 |
|
|
2020
Q1 | $4.38M | Buy |
98,161
+9,486
| +11% | +$498K | ﹤0.01% | 1091 |
|
|
2019
Q4 | $5.17M | Sell |
88,675
-9,388
| -10% | -$559K | ﹤0.01% | 1172 |
|
|
2019
Q3 | $5.89M | Buy |
98,063
+11,582
| +13% | +$690K | ﹤0.01% | 1144 |
|
|
2019
Q2 | $4.83M | Buy |
86,481
+5,040
| +6% | +$260K | ﹤0.01% | 1216 |
|
|
2019
Q1 | $4.54M | Buy |
81,441
+5,436
| +7% | +$277K | ﹤0.01% | 1189 |
|
|
2018
Q4 | $3.43M | Buy |
76,005
+5,057
| +7% | +$277K | ﹤0.01% | 1218 |
|
|
2018
Q3 | $4.67M | Buy |
70,948
+3,691
| +5% | +$229K | ﹤0.01% | 1161 |
|
|
2018
Q2 | $4.33M | Buy |
67,257
+13,811
| +26% | +$855K | ﹤0.01% | 1209 |
|
|
2018
Q1 | $2.96M | Buy |
53,446
+5,917
| +12% | +$310K | ﹤0.01% | 1310 |
|
|
2017
Q4 | $2.27M | Buy |
47,529
+2,745
| +6% | +$134K | ﹤0.01% | 1379 |
|
|
2017
Q3 | $2.26M | Buy |
44,784
+1,753
| +4% | +$90K | ﹤0.01% | 1351 |
|
|
2017
Q2 | $2.35M | Buy |
43,031
+3,124
| +8% | +$149K | ﹤0.01% | 1298 |
|
|
2017
Q1 | $1.68M | Sell |
39,907
-5,449
| -12% | -$233K | ﹤0.01% | 1417 |
|
|
2016
Q4 | $1.95M | Sell |
45,356
-12,998
| -22% | -$528K | ﹤0.01% | 1298 |
|
|
2016
Q3 | $2.41M | Sell |
58,354
-6,974
| -11% | -$292K | ﹤0.01% | 1307 |
|
|
2016
Q2 | $2.6M | Sell |
65,328
-18,852
| -22% | -$678K | ﹤0.01% | 1260 |
|
|
2016
Q1 | $2.83M | Sell |
84,180
-6,198
| -7% | -$193K | ﹤0.01% | 1225 |
|
|
2015
Q4 | $3.06M | Buy |
90,378
+1,588
| +2% | +$49.6K | ﹤0.01% | 1242 |
|
|
2015
Q3 | $2.64M | Buy |
88,790
+6,968
| +9% | +$218K | ﹤0.01% | 1297 |
|
|
2015
Q2 | $2.25M | Sell |
81,822
-11,102
| -12% | -$296K | ﹤0.01% | 1352 |
|
|
2015
Q1 | $2.34M | Sell |
92,924
-1,564
| -2% | -$37K | ﹤0.01% | 1298 |
|
|
2014
Q4 | $2.1M | Buy |
94,488
+75,650
| +402% | +$1.53M | ﹤0.01% | 1305 |
|
|
2014
Q3 | $382K | Hold |
18,838
| – | – | ﹤0.01% | 2012 |
|
|
2014
Q2 | $362K | Hold |
18,838
| – | – | ﹤0.01% | 2075 |
|
|
2014
Q1 | $354K | Buy |
18,838
+1,468
| +8% | +$28.3K | ﹤0.01% | 2075 |
|
|
2013
Q4 | $339K | Sell |
17,370
-1,468
| -8% | -$26.9K | ﹤0.01% | 2041 |
|
|
2013
Q3 | $310K | Hold |
18,838
| – | – | ﹤0.01% | 2065 |
|
|
2013
Q2 | $282K | Buy |
+18,838
| New | +$276K | ﹤0.01% | 2032 |
|
Other funds holding IART
RCMNY
PCMI
UBS AM's IART Position: Q2 2026 in Review
UBS AM reduced its Integra LifeSciences (IART) stake by 18% in Q2 2026, selling an estimated $477K and leaving 154,186 shares worth $2.77M. The position accounts for ﹤0.01% of the portfolio, ranked #1917.
UBS AM first reported a position in IART in Q2 2013 and has held it in 53 quarters since. The position peaked at $7.6M in Q4 2020. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.
- UBS AM held 154,186 shares of Integra LifeSciences worth $2.77M as of Q2 2026.
- UBS AM sold 34,116 Integra LifeSciences shares in Q2 2026, an estimated $477K.
- Integra LifeSciences made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #1917 holding.
- UBS AM first reported a position in Integra LifeSciences in Q2 2013 and has held it in 53 quarters since.
- UBS AM's Integra LifeSciences position peaked at $7.6M in Q4 2020.
- 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.
Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.